Delivery Order SPE2DB20D2104-SPE2DB21FT69Y
- Not listed
- This federal contract award, valued at $3,827.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to deliver POSACONAZOLE DR 100 MG TABLET 60S. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical, which runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $3,681.08, is a delivery order for 4562560501 - POSACONAZOLE DR 100 MG TABLET 60S. It is a firm fixed-price contract with an ultimate completion date of October 24, 2023. The contract was awarded on October 23, 2023, and there was no set-aside designation used. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
- This federal contract award is for the delivery of 4,562,841,818 units of POSACONAZOLE DR 100 MG TABLET 60S to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $29,449.54 and is a firm fixed price delivery order. The contract has no set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at up to $5,365.46, is for the delivery of 4564491405 POSACONAZOLE DR 100 MG TABLET 60S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of May 6, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,295.35, is for the delivery of POSACONAZOLE DR 100 MG TABLET 60S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 2, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $2,105.13, for the supply of POSACONAZOLE DR 100 MG TABLET 60S. The place of performance is Conshohocken, PA. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of POSACONAZOLE DR 100 MG TABLET 60S. The contract has a ceiling value of $3,272.91 and an ultimate completion date of March 19, 2025. It is a Firm Fixed Price contract and was not set aside for any specific socioeconomic category. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of POSACONAZOLE DR 100 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,681.28 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 3, 2025 and was awarded on February 28, 2025. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract, valued at $2,074.64, is for the delivery of POSACONAZOLE DR 100 MG TABLET 60S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,469.43, is for the supply of POSACONAZOLE DR 100 MG TABLET 60S, a medication used for the treatment of certain fungal infections. The contract is a firm fixed-price delivery order with a final completion date of July 5, 2024. The contract does not have a set-aside designation, indicating it...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB21FT69YDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4554455765 - POSACONAZOLE DR 100 MG TABLET 60S. The $2,434.67 firm fixed-price delivery order has an ultimate completion date of August 18, 2021. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which specializes in pharmaceutical distribution and supports various government healthcare programs, particularly within the Department of Defense (DoD) and Department of Veterans Affairs (VA). Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, serving as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to military treatment facilities globally. Additionally, the company maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 8/17/21 |